索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]王建,王焱.新型心脏置入器械血管入路和相关并发症的预防[J].国际心血管病杂志,2015,05:341-344.
点击复制

新型心脏置入器械血管入路和相关并发症的预防(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2015年05期
页码:
341-344
栏目:
综述
出版日期:
2015-09-25

文章信息/Info

Title:
-
作者:
王建; 王焱
361000 厦门市心血管病医院心脏科
Author(s):
-
关键词:
新型心脏置入器械; 血管入路; 血管入路并发症
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2015.05.014
文献标识码:
-
摘要:
经导管主动脉瓣置入(TAVI)、经导管左室分区术(PARACHUTE)等使用的鞘管较大,通常通过髂-股动脉入路,如发生入路并发症可影响患者预后。研究发现,经动脉TAVI患者的预后明显优于经心尖部TAVI的患者。优化新型心脏置入器械的入路策略是改善患者预后的关键。
Abstract:
-

参考文献/References

[1] Ducrocq G, Francis F, Serfaty JM, et al. Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome[J]. EuroIntervention,2010, 5:666-672.
[2] Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium[J].Eur Heart J,2011,32(2):205-217.
[3] Panchal HB, Ladia V, Amin P, et al. A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events in patients undergoing transfemoral versus transapical transcatheter aortic valve implantation using edwards valve for severe aortic stenosis[J]. Am J Cardiol,2014,114(12):1882-1890.
[4] Conrotto F, D'Ascenzo F, Francesca G, et al. Impact of access on TAVI procedural and midterm follow-up: a meta-analysis of 13 studies and 10,468 patients[J]. J Interv Cardiol,2014,27(5):500-508.
[5] Généreux P, Head SJ, Van Mieghem NM, et al. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies[J].J Am Coll Cardiol, 2012,59(25):2317-2326.
[6] Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document[J]. J Am Coll Cardiol,2012,60(15):1438-1454.
[7] Schymik G, Würth A, Bramlage P, et al. Long-term results of transapical versus transfemoral TAVI in a real world population of 1000 patients with severe symptomatic aortic stenosis[J]. Circ Cardiovasc Interv,2014,8(1). pii: e000761.
[8] Adamo M, Fiorina C, Curello S, et al. Role of different vascular approaches on transcatheter aortic valve implantation outcome: a single-center study[J]. J Cardiovasc Med(Hagerstown),2015,16(4):279-285.
[9] Allende R, Urena M, Cordoba JG, et al. Impact of the use of transradial versus transfemoral approach as secondary access in transcatheter aortic valve implantation procedures[J].Am J Cardiol,2014,114(11):1729-1734.
[10] Mwipatayi BP, Picardo A, Masilonyane-Jones TV, et al. Incidence and prognosis of vascular complications after transcatheter aortic valve implantation[J]. J Vasc Surg,2013,58(4): 1028-1036. e1.
[11] Hayashida K, Lefèvre T, Chevalier B, et al. Transfemoral aortic valve implantation new criteria to predict vascular complications[J]. JACC Cardiovasc Interv,2011,4(8):851-858.
[12] Reinthaler M, Aggarwal SK, De Palma R, et al. Predictors of clinical outcome in transfemoral TAVI: Circumferential iliofemoral calcifications and manufacturer-derived recommendations[J].Anatol J Cardiol,2015,15(4):297-305.
[13] Généreux P, Webb JG, Svensson LG, et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER(Placement of AoRTic TraNscathetER Valve)trial[J]. J Am Coll Cardiol,2012,60(12):1043-1052.
[14] Lange R, Bleiziffer S, Piazza N, et al. Incidence and treatment of procedural cardiovascular complications associated with trans-arterial and trans-apical interventional aortic valve implantation in 412 consecutive patients[J]. Eur J Cardiothorac Surg,2011,40(5):1105-1113.
[15] Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery[J]. N Engl J Med,2010,363(17):1597-1607.
[16] Toggweiler S, Webb JG. Challenges in transcatheter aortic valve implantation[J]. Swiss Med Wkly,2012,142:w13735.
[19] Hayashida K, Lefèvre T, Chevalier B, et al. True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: impact of learning curve on vascular complications[J]. JACC Cardiovasc Interv,2012,5(2):207-214.

备注/Memo

备注/Memo:
通信作者:王 焱,Email: wy@medmail.com.cn
更新日期/Last Update: 2015-10-20